Literature DB >> 18585456

Structures of TLR-ligand complexes.

Mi Sun Jin1, Jie-Oh Lee.   

Abstract

Toll-like receptors (TLRs) play central roles in the innate immune response by recognizing conserved structural patterns in diverse microbial molecules. The structures of the extracellular domains of four TLRs and their complexes with ligands have recently been determined by high-resolution X-ray crystallography. In this review, we describe these structures and discuss proposed activation mechanisms. TLRs deviate substantially from the canonical LRR structure and interact with a large variety of ligands in a highly divergent fashion. Agonistic ligands induce the formation of 'm' shaped TLR dimers in which the C-termini of the extracellular domains converge in the middle. This structural rearrangement of the extracellular domains suggests an activation mechanism that may be common to all TLR family proteins.

Mesh:

Substances:

Year:  2008        PMID: 18585456     DOI: 10.1016/j.coi.2008.06.002

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  31 in total

Review 1.  The leucine-rich repeat superfamily of synaptic adhesion molecules: LRRTMs and Slitrks.

Authors:  Jaewon Ko
Journal:  Mol Cells       Date:  2012-07-04       Impact factor: 5.034

2.  Structure-activity relationships in toll-like receptor 2-agonists leading to simplified monoacyl lipopeptides.

Authors:  Geetanjali Agnihotri; Breanna M Crall; Tyler C Lewis; Timothy P Day; Rajalakshmi Balakrishna; Hemamali J Warshakoon; Subbalakshmi S Malladi; Sunil A David
Journal:  J Med Chem       Date:  2011-11-04       Impact factor: 7.446

3.  Structure-activity relationships in human Toll-like receptor 2-specific monoacyl lipopeptides.

Authors:  Deepak B Salunke; Nikunj M Shukla; Euna Yoo; Breanna M Crall; Rajalakshmi Balakrishna; Subbalakshmi S Malladi; Sunil A David
Journal:  J Med Chem       Date:  2012-03-15       Impact factor: 7.446

4.  Structure-activity relationships in human toll-like receptor 7-active imidazoquinoline analogues.

Authors:  Nikunj M Shukla; Subbalakshmi S Malladi; Cole A Mutz; Rajalakshmi Balakrishna; Sunil A David
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

5.  Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists.

Authors:  Matthew D Morin; Ying Wang; Brian T Jones; Lijing Su; Murali M R P Surakattula; Michael Berger; Hua Huang; Elliot K Beutler; Hong Zhang; Bruce Beutler; Dale L Boger
Journal:  J Med Chem       Date:  2016-04-25       Impact factor: 7.446

Review 6.  Structural biology of innate immunity.

Authors:  Qian Yin; Tian-Min Fu; Jixi Li; Hao Wu
Journal:  Annu Rev Immunol       Date:  2015-01-22       Impact factor: 28.527

7.  Leucine-rich repeat 11 of Toll-like receptor 9 can tightly bind to CpG-containing oligodeoxynucleotides, and the positively charged residues are critical for the high affinity.

Authors:  Xichun Pan; Junjie Yue; Guofu Ding; Bin Li; Xin Liu; Xinchuan Zheng; Mengchen Yu; Jun Li; Weiwei Jiang; Chong Wu; Jiang Zheng; Hong Zhou
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

8.  Lung dendritic cells at the innate-adaptive immune interface.

Authors:  Tracy Voss Condon; Richard T Sawyer; Matthew J Fenton; David W H Riches
Journal:  J Leukoc Biol       Date:  2011-08-01       Impact factor: 4.962

9.  Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists.

Authors:  Matthew D Morin; Ying Wang; Brian T Jones; Yuto Mifune; Lijing Su; Hexin Shi; Eva Marie Y Moresco; Hong Zhang; Bruce Beutler; Dale L Boger
Journal:  J Am Chem Soc       Date:  2018-10-16       Impact factor: 15.419

Review 10.  Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.

Authors:  Bo Jin; Tao Sun; Xiao-Hong Yu; Chao-Qun Liu; Ying-Xiang Yang; Ping Lu; Shan-Feng Fu; Hui-Bin Qiu; Anthony E T Yeo
Journal:  J Biomed Biotechnol       Date:  2010-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.